期刊文献+

组织因子途径抑制物与急性心肌梗死 被引量:2

下载PDF
导出
摘要 组织因子(tissue factor,TF)是一种广泛存在于多种组织细胞浆膜上的糖蛋白,是凝血级联的主要始动因子,在外源性凝血途径中起着关键性的作用。而组织因子途径抑制物(tissue factor pathway inhibitor。TFPI)是迄今为止发现的外源性凝血途径的唯一特异性生理抑制物,能阻止血栓形成。
出处 《实用医学杂志》 CAS 北大核心 2011年第2期321-323,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献19

  • 1Crawley J, Andrew F, Westmuekett D, et al. Expression,localization,and activity of tissue factor pathway inhibitor in normal and atheroselerotie human vessels [J].Arteioscler Thromb Vase Boil, 2000,20(5) : 1362-1373. 被引量:1
  • 2Bajaj M S, Tyson D R, Sarah A, et al. Role of GATA motif in tissue factor pathway inhibitor gene expression in malignant cells [J]. Thromb Res, 2001,101 (3) :203-211. 被引量:1
  • 3Steppich B,Mattisek C,Sobozyk D,et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction [ J ]. Thromb Haemost, 2005,93 ( 1 ) : 35-39. 被引量:1
  • 4Levi M, Keller Tr, van Gorp E, et al. Infection and inflammation and the coaglllation system [J]. Cardiovase Res, 2003,60( 1 ) : 26-39. 被引量:1
  • 5Maly M, Vojacek J, Hrubos V, et al. Tisue factor, tissue factor pathway inhibi-tor and cytoadhesive molecules in patients with an acute corollary syndrome [J]. Physiol Res, 2003,52 (6):719-728. 被引量:1
  • 6时辉宁,钟玉绪,丁日高,廖明阳.组织因子途径抑制物-2的结构及其生物学作用研究进展[J].中国医药生物技术,2009,4(3):233-235. 被引量:2
  • 7Zaman A G, Helft G, Worthley S G, et al. The role of plaque rupture and thrombosis in coronary artery disease [J]. Atherosclerosis, 2000,149(2) : 251-266. 被引量:1
  • 8Banai S, Gertz S D. Tissue factor as therapeutic target in coronary syndromes [J]. Am J Cardiol, 2001, 87(6) :763-765. 被引量:1
  • 9Moons A H, Levi M, Peters R J. Tissue factor and coronary artery disease [J]. Cardiovasc Res, 2002,53 (2) :313-325. 被引量:1
  • 10Ardissino D, Merlini P A, Arlens R, et al. Tissue factor in human coronary atherosclerotic plaques [ J ]. Clin Chim Acta, 2000,219 (2) : 235-240. 被引量:1

二级参考文献25

  • 1顾俊,王长谦.基质金属蛋白酶与冠脉再狭窄[J].心脏杂志,2005,17(1):77-80. 被引量:5
  • 2Chenqi ZHANG,Desheng KONG,Xingang LIU,Xiaomin YAN,Linsen DAI,Duan MA.Spectroscopic Analysis on the Effect of Temperature on Kunitz Domain 1 of Human Tissue Factor Pathway Inhibitor-2[J].Acta Biochimica et Biophysica Sinica,2007,39(6):406-412. 被引量:3
  • 3Schecter A.D.,Giesen P.L.A.,et al.Tissue factor expression in human arterial smooth muscle cells.TF is present in three cellular pools after growth factor stimulation[ J].Journal of Clinical Investigations,100,2276-2285. 被引量:1
  • 4Maly M,Vojacek J,Harbos V,et al.Tissue factor,tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome[J].Physoil Res,2003,52(6):719 -728. 被引量:1
  • 5Steppich B,Mattisek C,sobczyk D,et al.Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction[ J ].Thromb Haemost,2005,93 (1):35-39. 被引量:1
  • 6Ardissino D,Merlini PA,Arlens R,et al.Tissue factor antigen and activity in human coronary atherosclerotic plaques[J].Lancet,1997,349:769-771. 被引量:1
  • 7Carter AM,Leatham EM,Math PMW,et al.Inflammation,thrombosis and acute coronary syndromes[ J ].Diab Vasc Dis Res,2005,2(3):113 -121. 被引量:1
  • 8Steppich B,Mattisek C,Sobczyk D,et al.Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction[ J ].Thromb Haemost,2005,93 (1):35-39. 被引量:1
  • 9Falciani M,Gori AM,Fedi S,et al.Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischemic heart diseases patients[ J ].Thromb Haemost,1998,79:495-499. 被引量:1
  • 10Soejima H,Ogawa H,Yause H,et al.Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina[ J ].Circulation,1999,(22):2908-2913. 被引量:1

共引文献5

同被引文献26

  • 1李中原,涂秀华.红花黄色素的药理研究进展[J].中药新药与临床药理,2005,16(2):153-156. 被引量:113
  • 2管高峰,华先平,王琳,杜令,孔祥辉.丹红注射液对动脉粥样硬化家兔脂代谢及血管内皮功能的影响[J].临床心血管病杂志,2007,23(4):304-306. 被引量:107
  • 3李亚里,杨怡卓.人乳头瘤病毒亚型检测在宫颈病变分流管理中的意义[J].中国实用妇科与产科杂志,2007,23(7):501-503. 被引量:55
  • 4Patterson C, Stouffer GA, Madamanchi N, et al. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology[J]. Circ Res, 2001, 88(10): 987-997. 被引量:1
  • 5Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor [J]. Proc Natl Acad Sci U S A, 1991, 88 (9): 3739-3743. 被引量:1
  • 6Ferns GA, Avades TY. The mechanisms of coronary restenosis: insights from experimental models[J]. Int J Exp Pathol, 2000, 81 (2): 63-88. 被引量:1
  • 7Wang L, Miller C, Swarthout RF, et al. Vascular smooth musclederived tissue factor is critical for arterial thrombosis after ferric chloride induced injury[J]. Blood, 2009, 113(3): 705-713. 被引量:1
  • 8Kopp CW, Holzenbein T, Steiner S, et al. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity[J]. Blood, 2004, 103(5): 1653-1661. 被引量:1
  • 9Tang XF, Liu JJ, Wu YJ, et al. Effect of hirulog-like peptide on balloon catheter injury-induced neointimal formation in femoral arteries of minipigs and relationship with inflammatory mediators [J]. J Vasc Res, 2010, 47(3): 262-269. 被引量:1
  • 10Drachman DE, Simon DI. Inflammation as a mechanism and therapeutic target for in-stent restenosis [J]. Curr Atheroscler Rep, 2005, 7(1): 44-49. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部